PANCHSHEEL ORGANICS
|
The Current P/E Ratio of PANCHSHEEL ORGANICS is 13.83.
| Share Price | ₹107.9 | Nov 11,2026 |
| Market Cap | ₹142.4 Cr | |
| Earnings-TTM | ₹10.3 Cr | TTM-Standalone Results |
| Price/Earnings | 13.83x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of PANCHSHEEL ORGANICS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹142.4 Cr] as on Nov 11,2026
(/) Earnings [ ₹10.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 13.83x ]
Thus, for PANCHSHEEL ORGANICS , the investors are currently willing to pay 13.83 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of PANCHSHEEL ORGANICS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of PANCHSHEEL ORGANICS over the last five years.
Historical PE (Price/Earnings) ratio chart of PANCHSHEEL ORGANICS
PE Ratio Performance Analysis for PANCHSHEEL ORGANICS
- PANCHSHEEL ORGANICS 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 14.99x.
- PANCHSHEEL ORGANICS 's operated at median p/e ratio of 14.49x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PANCHSHEEL ORGANICS 's p/e ratio peaked in Mar2022 at 18.37x.
- PANCHSHEEL ORGANICS 's p/e ratio hit its five-year low in Mar2026 of 10.97x.
How does PANCHSHEEL ORGANICS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| PANCHSHEEL ORGANICS | 10.30 | 13.83 | 142.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 41.22 | 454,914.0 |
| DIVIS LABORATORIES LTD | 3,363.00 | 89.32 | 300,380.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 86.31 | 181,169.0 |
| CIPLA LTD | 2,868.29 | 39.91 | 114,478.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 41.65 | 114,933.0 |
| MANKIND PHARMA LTD | 2,249.69 | 48.78 | 109,746.0 |
| LUPIN LTD | 5,221.47 | 17.70 | 92,418.9 |
| ZYDUS LIFESCIENCES LTD | 4,159.00 | 28.54 | 118,713.0 |
| AUROBINDO PHARMA LTD | 3,993.05 | 26.30 | 105,006.0 |
| LAURUS LABS LTD | 1,333.75 | 98.64 | 131,566.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs PANCHSHEEL ORGANICS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 13.83x |
| Max industry PE | 98.64x |
| Median industry PE | 41.22x |
| Average industry PE | 48.38x |
You may also like the below Video Courses